This article is intended for primary care clinicians, orthopaedists, and other specialists who care for patients with ingrown toenails.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 350 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/08. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity.
Note: Total credit is subject to change based on topic selection and article length.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 2/20/2009
Valid for credit through: 2/20/2010, 11:59 PM EST
processing....
February 20, 2009 — A review published in the February 15 issue of American Family Physician discusses risk factors, conservative therapy, and surgical approaches regarding management of the ingrown toenail in primary care.
"Approximately 20 percent of patients presenting to a family physician with a foot problem have an ingrown toenail, also known as onychocryptosis," write Joel J. Heidelbaugh, MD, and Hobart Lee, MD, from the University of Michigan in Ann Arbor. "Ingrown toenails occur when the periungual skin is punctured by its corresponding nail plate, resulting in a cascade of foreign body, inflammatory, infectious, and reparative processes. Ultimately, this may result in a painful, draining, and foul-smelling lesion of the involved toe (most commonly, the hallux nail), with soft tissue hypertrophy around the nail plate."
Anatomic and behavioral factors that may predispose to onychocryptosis may include incorrect methods of nail trimming, repetitive or unintentional trauma, genetic risk factors, hyperhidrosis, and poor foot hygiene. Wider nail folds and thinner, flatter nails are thought to increase the risk for ingrown toenails, but this is still unproven.
To help prevent onychocryptosis, toenails should be cut straight across and not pointed or too short, and the corners should not be rounded off.
Medical conditions associated with onychocryptosis include diabetes, obesity, as well as thyroid, cardiac, and kidney diseases that may predispose to lower extremity edema.
Ingrown toenail can be characterized as mild to moderate, in which the lesion gives rise to minimal to moderate pain with pressure, little erythema, and no purulent drainage. Mild cases are associated with nail-fold swelling and edema, and moderate cases with increased swelling, possible seropurulent drainage, infection, and ulceration of the nail fold.
Moderate to severe ingrown toenail is associated with severe, disabling pain, marked erythema, and purulent drainage. In the most severe cases of onychocryptosis, there is chronic inflammation, granulation, and marked nail-fold hypertrophy. Even for moderate to severe lesions, antibiotic use is not routinely recommended because it has not been shown to decrease healing time, postoperative morbidity, or recurrence rates.
Indications for the treatment of ingrown toenail include significant pain or infection; deformed, curved nail known as onychogryposis; or chronic, recurrent nail-fold inflammation (paronychia).
Conservative approaches to therapy are appropriate for initial management of mild to moderate ingrown toenail. These may include foot soaks in warm, soapy water and application of topical antibiotic ointment or mid-potency to high-potency steroid cream or ointment; placement of cotton wisps or dental floss under the edge of the ingrown toenail; and gutter splinting, which may sometimes involve the placement of a sculptured acrylic nail.
When conservative therapy fails for initial management of moderate to severe onychocryptosis, surgical treatments may be appropriate, such as partial nail avulsion or complete nail excision with or without phenolization. For treatment of ingrown toenails, partial nail avulsion followed by either phenolization or direct surgical excision of the nail matrix is equally effective.
For the prevention of symptomatic recurrence of ingrown toenails, partial avulsion of the lateral nail plate plus phenolization has been shown to be more effective than surgical excision of the nail without phenolization. However, the risk for postoperative infection is slightly increased with avulsion plus phenolization. Administration of oral antibiotics before or after phenolization has not been shown to improve outcomes.
When there is postoperative recurrence with pain and infection, the germinal matrix tissue should be permanently destroyed with phenolization (application of 80% - 88% phenol solution), electrocautery, radiofrequency, or carbon dioxide laser ablation of the the nail matrix.
Contraindications to surgical therapy include allergy to local anesthetics, bleeding disorder, or pregnancy if phenol use is considered.
All patients undergoing toenail surgery should receive appropriate education regarding postoperative care.
Specific recommendations for clinical practice, and their accompanying level of evidence rating, are as follows:
"Overaggressive electrocautery or radiofrequency ablation to the nail matrix may damage the adjacent and underlying fascia or periosteum," the review authors conclude. "If the toe is healing poorly several weeks after the procedure, debridement, oral antibiotics, and radiographic evaluation may be warranted. Patients should be instructed before the procedure that the appearance of the affected nail will be permanently altered and that the recess created by the removal of the nail and granulation tissue will gradually resolve to a somewhat normal appearance."
The review authors have disclosed no relevant financial relationships.
Am Fam Physician. 2009;79:303-308.
Ingrown toenails are a common problem in primary care practices, and many factors have been hypothesized to contribute to abnormal toenail growth and ingrown toenails. These factors include anatomic variations such as wider nail folds and thinner, flatter nails. In addition, genetics, family history, hyperhidrosis, trauma, and poor foot hygiene may also promote ingrown toenails. Finally, diseases that promote lower extremity edema can contribute to a higher risk for ingrown toenail. However, limited clinical data support most of these factors as risks for ingrown toenails.
The current review describes the characterization and management of ingrown toenails.